Back
Jasper Therapeutics Stock Predictions
Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
45
JSPR
Jasper Therapeutics
Last Price:
$4.77
Seasonality Move:
-13.99%
7 Day Trial
ALL ACCESS PASS
$
7
Pacaso has reserved the Nasdaq ticker PCSO and is offering shares at just $2.80 - but only until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with NasdaqJasper Therapeutics Stock Forecast
-
Is Jasper Therapeutics Stock Undervalued?The current Jasper Therapeutics [JSPR] share price is $4.77. The Score for JSPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
JSPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Jasper Therapeutics Stock Go Up Next Year?
Data Unavailable
Jasper Therapeutics Stock Rating
Data Unavailable
Jasper Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
jaspertherapeutics.com
52-Week Data
52-Week High:
26.84
52-Week Low:
3.13
Prediction Charts
Market Cap:
71.7M
Price in USD:
4.77
Volume:
91K
Beta:
2.16
Technical Analysis
SMA50:
4.66
SMA100:
6.48
SMA200:
13.38
52-Wk Change:
-79.97%
Stock Predictions
-
Is Jasper Therapeutics stock public?Yes, Jasper Therapeutics is a publicly traded company.
-
What is the Jasper Therapeutics stock quote today?The Jasper Therapeutics stock price is 4.77 USD today.
-
How to buy Jasper Therapeutics stock online?You can buy Jasper Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 5.15 | 4.74 | 5.16 | 4.56 |
| May-7 | 4.77 | 4.32 | 4.90 | 4.27 |
| May-8 | 4.37 | 4.43 | 4.76 | 4.30 |
| May-9 | 4.50 | 4.52 | 4.76 | 4.33 |
| May-12 | 4.73 | 4.74 | 4.99 | 4.56 |
| May-13 | 4.94 | 4.82 | 4.98 | 4.55 |
| May-14 | 4.85 | 4.85 | 5.00 | 4.60 |
| May-15 | 4.85 | 4.87 | 4.89 | 4.68 |
| May-16 | 4.93 | 4.93 | 5.09 | 4.86 |
| May-19 | 4.93 | 5.02 | 5.20 | 4.92 |
| May-20 | 5.00 | 5.04 | 5.11 | 4.96 |
| May-21 | 5.03 | 4.82 | 5.09 | 4.57 |
| May-22 | 4.81 | 4.87 | 4.96 | 4.72 |
| May-23 | 4.81 | 4.77 | 4.90 | 4.72 |
Jasper Therapeutics Earnings
Data Unavailable
Jasper Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.27 per share, an increase next quarter of $0.07 per share, a decrease this year of $1.01 per share, and an increase next year of $0.06 per share.
* Jasper Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.